Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Thermofisher is involved with Uk diagnostics and the lighthouse labs .. their s.p is steadily rising .. I have always believed PRM know how and their proteomics software will be pioneering in these labs for chemists and biotech start ups
Hello Henry , Thankyou so much. That means a lot to me as sometimes it like I’m talking to myself. it will be nice when more of us can have a discussion .. Welcome to the BB and may 2021 be a good year for us all .
I am recent investor in this company and I appreciate your posts Angel.
I can’t see why PRM isn’t broadcasting itself from the rooftops for all n sundry to see .. proteomics is the next big study area for biotechnology and medicine ?!!!
Get on with it , proteome sciences!!
https://www.pharmiweb.com/press-release/2020-12-21/proteomics-market-growing-with-highest-demand-by-2026-with-thermo-fisher-scientific-corporation-a
Low float makes the rise higher .. so limited shares and the spread has reduced significantly making it better for investors .. I just hope we hear some bright news soon
Here is an opportunity for PRM.New strains of COVID,develop a test that can differentiate between the various strains so that each can be treated accordingly with the relevant vaccine,testing is supposedly their forte.No doubt they will look on while someone else does it and then publish a thesis in some obscure journal on what could have been if they had moved quicker.
Given the appalling attitude of PRM to the average PI,I would say Diggle wishes he had never bought 1 share,let alone the millions he does own,an absolute shambles of a company.
He’s holding 83million shares there unless I am mistaken . Maybe proteome science feeds in to that company doing their analysis and testing
He seems to be busy buying shares in Scancell these days, £25k worth yesterday
Probably the same as the rest of us,checking in daily to see if these are still going or not and why he bothered investing so much.I see Mariola still hasn’t introduced herself to the 5 shareholders as yet,3 months and counting,strange.
Where is Martin ? Very low profile atm as well considering how big his stake is.
Nice to see us above the 4.00 limit ! Would love to know what’s happening proteome sciences ? It doesn’t cost much to tweet an update !
Thermofisher has been doing good lately . I hope they are marketing and selling tmtpro to all chemists, scientists and labs for better accurate and fuller quantitative proteomics data. You want the best tools in biotech disease study and drug development.
Strange , market makers, up and down, hold etc tmtpro starting to be noticed in field of some scientists for better results windows
No one has any idea what prm are up to because of their continued silence, shareholder/market communications are non existant
WTF are these playing at.??
16-plex TMTPro.
In comparison to maxquant software we have better data software !!! See @pwilmarth on Twitter . The increase in peptide spectrum
Matches has ranged from 20% to 40% in many comparisons.
It’s not moved much in a while but today has been quite good .. it doesn’t mean it won’t go up though .. I was just reading about max quant software package for proteomics. See more info here
https://www.google.co.uk/amp/s/proteomiclandscapes.wordpress.com/2016/03/16/uncovering-the-world-of-maxquant/amp/
Maybe the new ceo is making a difference. Are these worth buying?
Very interesting article .. although I suspect they r already on top of this and r using this .. the vaccine for Covid is also sure to have something in it to identify who has taken it ; like fluorescent markers for the masses which is like a liquid chip.
https://www.scienceboard.net/index.aspx?sec=sup&sub=can&pag=dis&ItemID=1665
Hey proteome need help
Managing ur marketing ? Check out
@ChroMarketingUK
Do you have a #chromatography company or product to promote?
Does your company Twitter account need managing?
DM us.
Because that’s what we do.
The Sohngens incorporated Paion HQ in Aachen & the ceo was the chief medical officer, with her close links to Humanwell BV & the proximity of the Frankfurt lab surely theres an open goal for prm to at least provide testing services for phase 3 trials
PAION ANNOUNCES PROGRESS WITH REMIMAZOLAM BY ITS PARTNER YICHANG HUMANWELL IN CHINA
- Recent launch of Ruima(R) (remimazolam) in procedural sedation
- Yichang Humanwell has started a Phase III trial in general anesthesia
Aachen (Germany), 11 August 2020 - The Specialty Pharma Company PAION AG (ISIN DE000A0B65S3; Frankfurt Stock Exchange Prime Standard: PA8) today announces that its Chinese remimazolam licensee Yichang Humanwell has recently launched Ruima(R) (remimazolam) in procedural sedation in China. In addition, a Phase III trial in general anesthesia in China has started patient recruitment. The Phase III study is a multicentre, single-blind randomized comparative clinical trial of efficacy and safety of remimazolam versus propofol in induction and maintenance of general anesthesia in 516 elective surgery patients.
Remimazolam (brand name Ruima(R)) was approved in China for procedural sedation in July 2020.
A bioinformatician combines research in biology, medicine, and health-related studies with information technology in order to collect and interpret data covering a range of fields, such as genetics or pharmaceutics
Why isn’t TMTPRO being broadcast more by thermofisher?
TMTPro improves complementary ion formation efficiency to the same level as both reporter ion-based quantification methods.
https://www.biorxiv.org/content/10.1101/2020.10.13.338244v1
I'm still wondering why has she taken the prm ceo job, if not with a mandate to sell it.
Soehngen, has been mandated by YHW to found and manage YHW´s European subsidiary to be established in H1 2020 as co-CEOs
https://troutaccess.com/investor.php/participatingcompanies/details/company_hash/8ae3c4b878c5c67f2a0fdf6e42a838c7/conference_hash/9cb784a9d56b966d048414948796f653
The Soehngens are excited to work together - again - as the designated Co-CEOs of Humanwell Pharmaceuticals Europe B.V. in foundation
https://de.linkedin.com/in/wolfgang-s%C3%B6hngen-60b2951
Wee nice rise and then .. as there is no news people
Are either in the know or think they have potential
As a world leader in Proteomics like I do but it is incredibly frustrating they don’t do a thing to communicate unless like before they noticed the share price rise and had to put a rns to dampen spirits .. Martin diggle has loads of shares here .. mariola has the right knowledge to take us somewhere in cancers/disease markers /immunotherapies .. ther is so much that could be done .. I would be advertising their capabilities to biotechs far and wide to help them develop accurate research and drugs